World Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

World Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,019	Closed	-$201K	–	1341
2018 Q1	$201K	Sell	2,019 -851	-30%	-$91.7K	0.01%	1225
2017 Q4	$269K	Sell	2,870 -113	-4%	-$10.7K	0.01%	1202
2017 Q3	$304K	Sell	2,983 -8	-0.3%	-$699	0.01%	1124
2017 Q2	$229K	Buy	+2,991	New	+$252K	0.01%	1274

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

World Asset Management's LKFT Position: Q2 2018 in Review

World Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2018, closing a stake of 2,019 shares — an estimated $201K sold.

World Asset Management first reported a position in LKFT in Q2 2017 and held it in 4 quarters. The position peaked at $304K in Q3 2017. 79 funds tracked by Wall St. Rank hold LKFT as of Q2 2018.

World Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2018 after selling out during the quarter.
World Asset Management sold 2,019 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2018, an estimated $201K.
World Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 4 quarters.
World Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $304K in Q3 2017.
79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2018.

Based on World Asset Management's 13F filing for Q2 2018, filed 18 Jul 2018.